These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 2843672
1. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB. J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672 [Abstract] [Full Text] [Related]
2. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB. Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [Abstract] [Full Text] [Related]
4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR. Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [Abstract] [Full Text] [Related]
5. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells. Murray RJ, Brooks JM, Rickinson AB, Rowe M. Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661 [Abstract] [Full Text] [Related]
6. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG. Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426 [Abstract] [Full Text] [Related]
7. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB. J Virol; 1990 May 01; 64(5):2126-34. PubMed ID: 2157875 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line. Zhang Q, Brooks L, Busson P, Wang F, Charron D, Kieff E, Rickinson AB, Tursz T. Eur J Immunol; 1994 Jun 01; 24(6):1467-70. PubMed ID: 8206105 [Abstract] [Full Text] [Related]
9. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains. Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB. J Virol; 1988 Mar 01; 62(3):894-901. PubMed ID: 2828684 [Abstract] [Full Text] [Related]
10. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. J Exp Med; 1992 Jul 01; 176(1):157-68. PubMed ID: 1319456 [Abstract] [Full Text] [Related]
11. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG. Eur J Immunol; 1990 Oct 01; 20(10):2293-9. PubMed ID: 2173662 [Abstract] [Full Text] [Related]
12. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G. Proc Natl Acad Sci U S A; 1987 Jul 01; 84(13):4567-71. PubMed ID: 3037521 [Abstract] [Full Text] [Related]
13. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Khanna R, Burrows SR, Nicholls J, Poulsen LM. Eur J Immunol; 1998 Feb 01; 28(2):451-8. PubMed ID: 9521052 [Abstract] [Full Text] [Related]
14. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E. Proc Natl Acad Sci U S A; 1987 May 01; 84(10):3452-6. PubMed ID: 3033649 [Abstract] [Full Text] [Related]
15. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222 [Abstract] [Full Text] [Related]
17. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. Contreras-Salazar B, Ehlin-Henriksson B, Klein G, Masucci MG. J Virol; 1990 Nov 01; 64(11):5441-7. PubMed ID: 2170681 [Abstract] [Full Text] [Related]
18. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids. Contreras-Salazar B, Klein G, Masucci MG. J Virol; 1989 Jun 01; 63(6):2768-72. PubMed ID: 2542588 [Abstract] [Full Text] [Related]
19. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells. Doyle MG, Crawford DH. Intervirology; 1994 Jun 01; 37(5):236-44. PubMed ID: 7698878 [Abstract] [Full Text] [Related]
20. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G. J Virol; 1989 Jul 01; 63(7):3135-41. PubMed ID: 2470924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]